Partner, SR One
Deborah Harland joined SR One in 2005 to establish the firm’s European investment office. She has extensive operational, drug development and licensing experience gained in numerous clinical development, medical affairs and business development roles during her more than 25 year tenure in the pharmaceutical industry. In addition to her responsibilities at Mission, Deborah is a Board Director of Bicycle Therapeutics, F-star, VHsquared, and Asceneuron and an observer on the Boards of Pulmocide and Psioxus Therapeutics. She is also an independent director at Cancer Research Technology.